Effects of Jianpi Bushen Therapy for Treatment of CKD Anemia: A Meta-Analysis of Randomized Controlled Trials

Liang Li,Chengyin Li,Yu Zhou,Qi Xu,Zilin Wang,Xiaoyun Zhu,Yuanming Ba

DOI: https://doi.org/10.3389/fphar.2020.560920

IF: 5.6

2020-09-15

Frontiers in Pharmacology

Abstract:<span><strong>Objectives:</strong> To evaluate the efficacy of Traditional Chinese Medicine, specifically Jianpi Bushen (JPBS) therapy, for treatment of patients with chronic kidney disease (CKD) anemia.<strong>Methods:</strong> Randomized controlled trials of JPBS therapy for CKD anemia were searched and selected from seven electronic databases. The Cochrane collaboration tool was used to conduct methodological quality assessment. RevMan v5.3 software was utilized to perform data analysis.<strong>Results:</strong> In total, 12 randomized controlled trials with 799 patients met the meta-analysis criteria. The aggregated results indicated that JPBS therapy is beneficial for CKD anemia by improving the clinical efficacy rate [risk ratio (RR) = 1.23, 95% confidence interval (CI): (1.14, 1.33), <i>P</i> &lt; 0.00001] and hemoglobin (Hb) [weighted mean difference (WMD) = 9.55, 95% CI: (7.97, 11.14), <i>P</i> &lt; 0.00001], serum ferritin (SF) [WMD = 6.22, 95% CI: (2.65, 9.79), <i>P</i> = 0.0006], red blood cell (RBC) [WMD = 0.31, 95% CI: (0.24, 0.38), <i>P</i> &lt; 0.00001], hematocrit (HCT) [WMD = 2.95, 95% CI: (2.36, 3.54), <i>P</i> &lt; 0.00001], serum creatinine (SCr) [WMD = 64.57, 95% CI: (33.51, 95.64), <i>P</i> &lt; 0.0001], and blood urea nitrogen (BUN) levels [WMD = 3.76, 95% CI: (2.21, 5.31), <i>P &lt;</i>0.00001]. Furthermore, evidence suggests that JPBS therapy is safe and does not increase adverse reactions compared with western medicine (WM) alone.<strong>Conclusion:</strong> This study found that JPBS therapy has a positive effect on the treatment of CKD anemia. However, more well-designed, double-blind, large-scale randomized controlled trials are needed to assess the efficacy of JPBS therapy in the treatment of CKD anemic patients.</span>

pharmacology & pharmacy

What problem does this paper attempt to address?

### What problem does this paper attempt to solve?

This paper aims to evaluate the efficacy of the Jianpi Bushen (JPBS) therapy for patients with chronic kidney disease anemia (CKD anemia). Specifically, the study uses a meta-analysis approach to synthesize data from multiple randomized controlled trials (RCTs) to assess the effectiveness of JPBS therapy in improving clinical outcomes for CKD anemia patients.

### Main findings of the study:

1. **Clinical efficacy**: Compared to using only Western medicine, the combination of JPBS therapy and Western medicine significantly improved the clinical efficacy for CKD anemia patients.
2. **Levels of Hemoglobin (Hb), Serum Ferritin (SF), Red Blood Cells (RBC), and Hematocrit (HCT)**: The combination of JPBS therapy and Western medicine significantly increased these levels.
3. **Levels of Serum Creatinine (SCr) and Blood Urea Nitrogen (BUN)**: JPBS therapy as an adjunct treatment reduced the levels of SCr and BUN in CKD anemia patients.
4. **Safety**: JPBS therapy did not increase the incidence of adverse reactions and was safer compared to using Western medicine alone.

### Conclusion:
The study indicates that JPBS therapy has a positive effect on treating CKD anemia. However, due to the low quality of the included studies and potential publication bias, more high-quality, double-blind, large-scale randomized controlled trials are needed to further verify the efficacy of JPBS therapy.